NEW YORK, Nov. 5 - Roche Holding is about to release a DNA-based test it developed with the Mayo Clinic that can help researchers identify anthrax faster than other products, the company said on Monday.

"The new test can identify the presence of anthrax in less than one hour instead of days," the Swiss pharmaceutical company said in a statement.

Roche will provide the product beginning next week at no charge to roughly 24 laboratories in the United States that are equipped with its LightCycler PCR technology, the company said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.